Compounded GLP-1s can also be useful when a patient's need for unique additives or dosing schedule does not match any of the options currently available with brand name GLP-1 medications
Article Title : [Not specified in the provided content] News Publication Date : [Not specified in the provided content] Web References : doi:10.1001/jamahealthforum.2025.4258 Keywords : Peptides, Agonists, Cohort studies, Racial differences, Ethnicity, Medications, Pharmaceuticals, Health care costs, Health insurance Tags: chronic disease management inequalitieseconomic factors in medication adherenceGLP-1 receptor agonists prescription disparitiesglycemic control and weight managementhealthcare equity in pharmaceutical accessmedication adherence in type 2 diabetesnon-Hispanic Black and Hispanic health disparitiesout-of-pocket costs for diabetes medicationspolicy implications for diabetes careprescription fill rates by demographicrace and ethnicity in diabetes treatmentsystemic barriers in healthcare access
This approach addresses obesity as the chronic medical condition it is, similar to how medications manage diabetes, hypertension, or high cholesterol
In conclusion, the results of this study show an increase in the dispensation of GLP-1 RAs as well as a shift in patient characteristics and choice of substance and brand
Adjustments to the dose or frequency can be made as needed
If you experience any concerning symptoms, such as severe nausea or digestive issues, contact your healthcare provider
